Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis

被引：9
|
作者：
Anan, Go [1 ,2 ]
Kikuchi, Daisuke [3 ]
Hirose, Takuo [4 ,5 ,6 ]
Ito, Hiroki [4 ]
Nakayama, Shingo [4 ]
Mori, Takefumi [4 ,5 ]
机构：
[1] Yotsuya Med Cube, Dept Urol, 7-7 Nibancho,Chiyoda Ku, Tokyo 1020084, Japan
[2] Tohoku Med & Pharmaceut Univ, Fac Med, Sendai, Japan
[3] Tohoku Med & Pharmaceut Univ Hosp, Dept Pharm, Sendai, Japan
[4] Tohoku Med & Pharmaceut Univ, Div Nephrol & Endocrinol, Sendai, Japan
[5] Tohoku Med & Pharmaceut Univ, Div Integrat Renal Replacement Therapy, Sendai, Japan
[6] Tohoku Univ Grad Sch Med, Dept Endocrinol & Appl Med Sci, Sendai, Japan
来源：
KIDNEY INTERNATIONAL REPORTS | 2023年 / 8卷 / 04期
基金：
日本学术振兴会;
关键词：
diabetes; epidemiologic study; inflammation; metabolic syndrome; sodium-glucose cotransporter-2 inhibitor; urolithiasis;
D O I：
10.1016/j.ekir.2023.01.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：925 / 928
页数：4
相关论文
共 50 条
  • [1] The impact of sodium-glucose cotransporter-2 inhibitors on cardiac function
    Chen, I-Wen
    Weng, Hsiu-Lan
    Hung, Kuo-Chuan
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 130 - 131
  • [2] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [3] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [4] Erythrocytosis induced by sodium-glucose cotransporter-2 inhibitors
    Chin-Yee, Benjamin
    Solh, Ziad
    Hsia, Cyrus
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (42) : E1271 - E1271
  • [5] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
    Heerspink, Hiddo J. L.
    Kosiborod, Mikhail
    Inzucchi, Silvio E.
    Cherney, David Z. I.
    [J]. KIDNEY INTERNATIONAL, 2018, 94 (01) : 26 - 39
  • [6] Sodium-glucose cotransporter-2 inhibitors: where and when?
    Cowie, Martin R.
    [J]. FUTURE CARDIOLOGY, 2020, 17 (03) : 403 - 406
  • [7] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [8] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    [J]. HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [9] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Taylor McKenzie
    Genevieve M. Hale
    Amelia Miner
    Jean Colón Colón
    Garrett Evins
    Jasmine Wade
    [J]. Heart Failure Reviews, 2024, 29 : 549 - 558
  • [10] The impact of sodium-glucose cotransporter-2 inhibitors on the outcome of patients with colorectal adenocarcinoma
    Chiang, Cho Han
    Chiang, Cho Hung
    Hsia, Yuanping
    See, Xin Ya
    Wang, Shih-Syuan
    Chen, Yuan-Jen
    Peng, Chun-Yu
    Horng, Chuan-Sheng
    Wong, Kit Yee
    Jaroenlapnopparat, Aunchalee
    Liu, Weitao
    Chiang, Cho Hsien
    Shiah, Her-Shyong
    Neilan, Tomas G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345